Skip to content

EnteroBiotix vs PharmaBiome AG

EnteroBiotix logo

EnteroBiotix

Mastering the microbiome, transforming lives®

55 employees · est. 2017

VS
PharmaBiome AG logo

PharmaBiome AG

Pioneering the development of microbiome-based therapies using proprietary tools for their design and production

11 employees · est. 2015 · Zurich, Switzerland

PharmaBiome AG is the older company (2017 vs 2015); EnteroBiotix is the larger of the two.

Side-by-Side Comparison

EnteroBiotix PharmaBiome AG
Founded
2017 2015 older
Headquarters
Not tracked yet Zurich, Switzerland
Employees
55 larger 11
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care
Funding Stage
Venture round Convertible Note
Total Funding
$64.00M $1.98M
Funding Rounds
5 6
Taxonomy
Microbiome TherapeuticsGut MicrobiomeDisease TreatmentInfection ControlMedical InnovationMicrobiome Research +2 Microbiome-based TherapiesBiotherapeuticsMicrobiologyPatent-Protected TechnologyStart-up AwardsIntestinal Microbes +7
Website
enterobiotix.com pharmabiome.com
EnteroBiotix logo

About EnteroBiotix

EnteroBiotix is a leading microbiome therapeutics platform company that is focused on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to the structure and function of the gut microbiome. Founded in 2017, the company operates in the B...

PharmaBiome AG logo

About PharmaBiome AG

PharmaBiome AG is a Swiss-based startup that is pioneering the development of microbiome-based therapies using proprietary tools for their design and production. Founded in 2015 as a spin-off from ETH Zurich, the company has created a first-in-the-industry, patent-protected technology platform for t...

Also comparing in this category

Comparing more than these two?

Get EnteroBiotix, PharmaBiome AG and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does EnteroBiotix compare?

A PDF of EnteroBiotix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

EnteroBiotix was founded in 2017, with 55 employees. EnteroBiotix is a leading microbiome therapeutics platform company that is focused on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions. PharmaBiome AG was founded in 2015, based in Zurich, Switzerland, with 11 employees. PharmaBiome AG is a Swiss-based startup that is pioneering the development of microbiome-based therapies using proprietary tools for their design and production. Founded in 2015 as a spin-off from ETH.
EnteroBiotix has raised $64.00M and PharmaBiome AG $1.98M. Latest stage: EnteroBiotix Venture round, PharmaBiome AG Convertible Note.
Both work in Biotechnology and Health Care and list gut microbiome among their focus areas.

Compare EnteroBiotix with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EnteroBiotix on 12 Sep 2024, and PharmaBiome AG on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout